FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2098397327> ?p ?o ?g. }

• W2098397327 endingPage "11" @default.
• W2098397327 startingPage "7" @default.
• W2098397327 abstract "A number of agents that are used in the treatment of cancer have a suboptimal pharmacokinetic profile that necessitates prolonged or repetitive administration. Pegylation of these agents may help overcome these shortcomings without compromising the agents' efficacy. Several such pegylated agents have now been developed and evaluated in patients with oncology-related disorders. Pegfilgrastim (a pegylated form of filgrastim) has shown efficacy and tolerability that are at least equivalent to those of filgrastim in patients with chemotherapy-induced neutropenia and, unlike unmodified filgrastim, is effective with only one administration per chemotherapy cycle. Other promising pegylated agents are pegylated liposomal doxorubicin, which appears to be more effective and less cardiotoxic than unmodified orliposome-encapsulated doxorubicin, and peginterferon alpha-2a, as once-weekly treatment for renal cell carcinoma, Pegylated agents are likely to be more convenient for patients than the standard formulations, and the improved pharmacokinetics will enhance the clinical utility of these agents. A number of agents that are used in the treatment of cancer have a suboptimal pharmacokinetic profile that necessitates prolonged or repetitive administration. Pegylation of these agents may help overcome these shortcomings without compromising the agents' efficacy. Several such pegylated agents have now been developed and evaluated in patients with oncology-related disorders. Pegfilgrastim (a pegylated form of filgrastim) has shown efficacy and tolerability that are at least equivalent to those of filgrastim in patients with chemotherapy-induced neutropenia and, unlike unmodified filgrastim, is effective with only one administration per chemotherapy cycle. Other promising pegylated agents are pegylated liposomal doxorubicin, which appears to be more effective and less cardiotoxic than unmodified orliposome-encapsulated doxorubicin, and peginterferon alpha-2a, as once-weekly treatment for renal cell carcinoma, Pegylated agents are likely to be more convenient for patients than the standard formulations, and the improved pharmacokinetics will enhance the clinical utility of these agents." @default.
• W2098397327 created "2016-06-24" @default.
• W2098397327 creator A5006930823 @default.
• W2098397327 date "2002-01-01" @default.
• W2098397327 modified "2023-10-14" @default.
• W2098397327 title "Clinical uses of pegylated pharmaceuticals in oncology" @default.
• W2098397327 cites W1589920570 @default.
• W2098397327 cites W1936102867 @default.
• W2098397327 cites W1941542407 @default.
• W2098397327 cites W1966963151 @default.
• W2098397327 cites W1970523181 @default.
• W2098397327 cites W2007083789 @default.
• W2098397327 cites W2011707824 @default.
• W2098397327 cites W2012446208 @default.
• W2098397327 cites W202042235 @default.
• W2098397327 cites W2033922294 @default.
• W2098397327 cites W2100227035 @default.
• W2098397327 cites W2269955197 @default.
• W2098397327 cites W2332630894 @default.
• W2098397327 cites W4238856605 @default.
• W2098397327 doi "https://doi.org/10.1016/s0305-7372(02)80003-2" @default.
• W2098397327 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12173409" @default.
• W2098397327 hasPublicationYear "2002" @default.
• W2098397327 type Work @default.
• W2098397327 sameAs 2098397327 @default.
• W2098397327 citedByCount "53" @default.
• W2098397327 countsByYear W20983973272012 @default.
• W2098397327 countsByYear W20983973272013 @default.
• W2098397327 countsByYear W20983973272014 @default.
• W2098397327 countsByYear W20983973272015 @default.
• W2098397327 countsByYear W20983973272016 @default.
• W2098397327 countsByYear W20983973272017 @default.
• W2098397327 countsByYear W20983973272019 @default.
• W2098397327 countsByYear W20983973272022 @default.
• W2098397327 crossrefType "journal-article" @default.
• W2098397327 hasAuthorship W2098397327A5006930823 @default.
• W2098397327 hasConcept C10138342 @default.
• W2098397327 hasConcept C112705442 @default.
• W2098397327 hasConcept C126322002 @default.
• W2098397327 hasConcept C143998085 @default.
• W2098397327 hasConcept C162324750 @default.
• W2098397327 hasConcept C197934379 @default.
• W2098397327 hasConcept C2776694085 @default.
• W2098397327 hasConcept C2777063308 @default.
• W2098397327 hasConcept C2778375690 @default.
• W2098397327 hasConcept C2778658803 @default.
• W2098397327 hasConcept C2779149719 @default.
• W2098397327 hasConcept C2779171977 @default.
• W2098397327 hasConcept C54400483 @default.
• W2098397327 hasConcept C71924100 @default.
• W2098397327 hasConcept C98274493 @default.
• W2098397327 hasConceptScore W2098397327C10138342 @default.
• W2098397327 hasConceptScore W2098397327C112705442 @default.
• W2098397327 hasConceptScore W2098397327C126322002 @default.
• W2098397327 hasConceptScore W2098397327C143998085 @default.
• W2098397327 hasConceptScore W2098397327C162324750 @default.
• W2098397327 hasConceptScore W2098397327C197934379 @default.
• W2098397327 hasConceptScore W2098397327C2776694085 @default.
• W2098397327 hasConceptScore W2098397327C2777063308 @default.
• W2098397327 hasConceptScore W2098397327C2778375690 @default.
• W2098397327 hasConceptScore W2098397327C2778658803 @default.
• W2098397327 hasConceptScore W2098397327C2779149719 @default.
• W2098397327 hasConceptScore W2098397327C2779171977 @default.
• W2098397327 hasConceptScore W2098397327C54400483 @default.
• W2098397327 hasConceptScore W2098397327C71924100 @default.
• W2098397327 hasConceptScore W2098397327C98274493 @default.
• W2098397327 hasLocation W20983973271 @default.
• W2098397327 hasLocation W20983973272 @default.
• W2098397327 hasOpenAccess W2098397327 @default.
• W2098397327 hasPrimaryLocation W20983973271 @default.
• W2098397327 hasRelatedWork W2017214814 @default.
• W2098397327 hasRelatedWork W2035365523 @default.
• W2098397327 hasRelatedWork W2038513852 @default.
• W2098397327 hasRelatedWork W2100082529 @default.
• W2098397327 hasRelatedWork W2164788594 @default.
• W2098397327 hasRelatedWork W2241579338 @default.
• W2098397327 hasRelatedWork W2590956405 @default.
• W2098397327 hasRelatedWork W2958331463 @default.
• W2098397327 hasRelatedWork W4238856605 @default.
• W2098397327 hasRelatedWork W4321512784 @default.
• W2098397327 hasVolume "28" @default.
• W2098397327 isParatext "false" @default.
• W2098397327 isRetracted "false" @default.
• W2098397327 magId "2098397327" @default.
• W2098397327 workType "article" @default.